Concepedia

Publication | Open Access

Adalimumab for maintenance treatment of Crohn’s disease: results of the CLASSIC II trial

DOIFull Paper Access

1K

Citations

30

References

2007

Year

William J. Sandborn, S. B. Hanauer, P. Rutgeerts, Richard N. Fedorak, Milan Lukáš, Donald MacIntosh, Remo Panaccione, Douglas C. Wolf, Jeffrey D. Kent, Barry Bittle,
Gut

Abstract

Adalimumab induced and maintained clinical remission for up to 56 weeks in patients with moderate to severe Crohn's disease naive to anti-TNF treatment.

References

YearCitations

Page 1